Literature DB >> 12617260

Factors that predict health-related quality of life in patients with relapsing-remitting multiple sclerosis.

Deborah M Miller1, Richard A Rudick, Monika Baier, Gary Cutter, David S Doughtery, Bianca Weinstock-Guttman, Michele K Mass, Elizabeth Fisher, Nancy Simonian.   

Abstract

Health-Related Quality of Life (HRQoL) research is gaining acceptance in the field of multiple sclerosis (MS). Little is known about what precipitates quality of life change. It was hypothesized that physical aspects of quality of life decline with worsening objective disease measures and psychosocial aspects remain relatively stable regardless of change in objective measures. These assumptions are tested using data from a Phase 3 study of relapsing-remitting MS patients treated with interferon beta-1a and reassessed approximately eight years after study initiation. The Sickness Impact Profile (SIP) questionnaire is the generic quality of life measure used in this study. Three summary scores of the SIP (Physical, Psychosocial, and Total scores), Expanded Disability Status Scores, Multiple Sclerosis Functional Composite, and Brain Parenchymal Fraction were determined at baseline, year 2, and after an average of 8.1 years from study entry. SIP data collected during a clinic visit were available from 137 of the original 172 participants. All objective indicators worsened by follow-up. SIP Physical and Total scores significantly worsened from baseline to follow-up. SIP Psychosocial showed nonsignificant worsening. Regression analysis indicated that final measures of SIP Physical and Total scores were most strongly associated with change in objective measures and follow-up SIP Psychosocial was most strongly related to earlier scores on the same measure.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12617260     DOI: 10.1191/1352458503ms888oa

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  19 in total

1.  Longitudinal changes in social functioning in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study (II).

Authors:  Francesco Patti; Maria Pia Amato; Maria Trojano; Stefano Bastianello; Maria Rosalia Tola; Orietta Picconi; Sabina Cilia; Salvatore Cottone; Luigi M E Grimaldi
Journal:  Qual Life Res       Date:  2011-09-28       Impact factor: 4.147

2.  Change in the Health-Related Quality of Life of Multiple Sclerosis Patients over 5 Years.

Authors:  Wonita Janzen; Karen V L Turpin; Sharon A Warren; Ruth Ann Marrie; Kenneth G Warren
Journal:  Int J MS Care       Date:  2013

3.  Cognition and physical disability in predicting health-related quality of life in multiple sclerosis.

Authors:  Marietta Hoogs; Sukhmit Kaur; Audrey Smerbeck; Bianca Weinstock-Guttman; Ralph H B Benedict
Journal:  Int J MS Care       Date:  2011

4.  Impact and characteristics of quality of life in Japanese patients with multiple sclerosis.

Authors:  Hiromi Kikuchi; Nobuhiro Mifune; Masaaki Niino; Sadayoshi Ohbu; Jun-ichi Kira; Tatsuo Kohriyama; Kohei Ota; Masami Tanaka; Hirofumi Ochi; Shunya Nakane; Masaji Maezawa; Seiji Kikuchi
Journal:  Qual Life Res       Date:  2010-08-11       Impact factor: 4.147

Review 5.  [Quality of life in multiple sclerosis. Measures, relevance, problems, and perspectives].

Authors:  W Pöllmann; C Busch; R Voltz
Journal:  Nervenarzt       Date:  2005-02       Impact factor: 1.214

6.  Disability status and quality of life in multiple sclerosis: non-linearity of the Expanded Disability Status Scale (EDSS).

Authors:  Sabine Twork; Susanne Wiesmeth; Milena Spindler; Markus Wirtz; Sabine Schipper; Dieter Pöhlau; Jörg Klewer; Joachim Kugler
Journal:  Health Qual Life Outcomes       Date:  2010-06-07       Impact factor: 3.186

7.  Improvement of health-related quality of life in relapsing remitting multiple sclerosis patients after 2 years of treatment with intramuscular interferon-beta-1a.

Authors:  Peter Joseph Jongen; Christian Sindic; Herwig Carton; Cees Zwanikken; Wim Lemmens; George Borm
Journal:  J Neurol       Date:  2009-11-18       Impact factor: 4.849

8.  Percutaneous transluminal angioplasty for chronic cerebrospinal venous insufficiency in multiple sclerosis: dichotomy between subjective and objective outcome scores.

Authors:  Sara Zagaglia; Simona Balestrini; Eva Perticaroli; Maura C Danni; Simona Luzzi; Mauro Silvestrini; Leandro Provinciali
Journal:  Neurol Sci       Date:  2013-05-10       Impact factor: 3.307

9.  Oxidative Stress and Lymphocyte Alterations in Chronic Relapsing Experimental Allergic Encephalomyelitis in the Rat Hippocampus and Protective Effects of an Ethanolamine Phosphate Salt.

Authors:  Aranzazu Perianes-Cachero; María V T Lobo; Alberto M Hernández-Pinto; Rebeca Busto; Miguel Angel Lasunción-Ripa; Eduardo Arilla-Ferreiro; Lilian Puebla-Jiménez
Journal:  Mol Neurobiol       Date:  2019-09-10       Impact factor: 5.590

10.  Change in quality of life and predictors of change among patients with multiple sclerosis: a prospective cohort study.

Authors:  Darija Kisic Tepavcevic; Tatjana Pekmezovic; Nebojsa Stojsavljevic; Jelena Kostic; Irena Dujmovic Basuroski; Sarlota Mesaros; Jelena Drulovic
Journal:  Qual Life Res       Date:  2013-10-01       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.